REGENXBIO Inc. (RGNX)
Nasdaq • RGNX • US75901B1070
ORTEX Data Highlights
ORTEX Data Highlights
As of Oct 28, 2026, ORTEX estimated 17.7% of free float sold short, 7.2 days to cover, cost to borrow 0.46%. Sign up for live short interest data.
Market Cap
560m USD | # 5843 in US
Volume
1.38m shares | 11.44m USD
Shares Outstanding
66.12m
Free Float Shares
86.68% | 57.31m
